Dosilicon Co., Ltd.

Dositicon Co., Ltd. has experienced notable stock activity, achieving a significant annual increase despite recent challenges. The company reported positive results for three consecutive quarters, with a substantial reduction in raw material costs. Its market capitalization stands at CNY 59,102 million, reflecting its resilience in a competitive industry.

Dositicon Co., Ltd. faced notable stock volatility on March 23, 2026, with a significant decline amid broader market trends. Despite recent challenges, the company has shown impressive long-term growth. However, it grapples with profitability issues and declining net sales, while maintaining positive quarterly results and operating cash flow.

Dositicon Co., Ltd. faced a significant decline in stock value today, marking a challenging trading environment. Despite a strong long-term performance with a substantial annual increase, the company shows concerning financial metrics, including low Return on Capital Employed and negative net sales growth trends over the past five years.

Dositicon Co., Ltd. has experienced notable intraday gains, contrasting with a slight decline in the China Shanghai Composite. Over the past year, the company has significantly outperformed the broader market. Despite challenges such as low profitability and declining net sales growth, it has reported positive results in recent quarters.

Dositicon Co., Ltd. faced a notable decline in stock value today, reflecting a challenging trading environment. Despite recent setbacks, the company has achieved impressive long-term growth. However, it is grappling with a low Return on Capital Employed and a concerning trend in declining net sales over the past five years.

Dositicon Co., Ltd. saw a decline in stock value today, despite a strong annual growth of 364.6%. The company faces challenges, including a low Return on Capital Employed and a significant drop in net sales and operating profit over five years, though it has reported positive results in recent quarters.

Dosilicon Co. has experienced notable stock performance, gaining 3.23% on March 9, 2026, and achieving an intraday high of CNY 149.79. Over the past year, the stock has surged by 383.73%, despite challenges such as low Return on Capital Employed and declining net sales.

Dositicon Co., Ltd. has shown notable market activity, achieving significant gains today and over the past week and month. Despite challenges such as low profitability and declining sales over five years, the company has reported positive results in recent quarters, highlighting its strong long-term performance.

Dositicon Co., Ltd. has seen a notable increase in its stock price, reaching an intraday high while outperforming the broader market over the past year. Despite facing challenges like low ROCE and declining net sales, the company has reported positive results for three consecutive quarters and reduced raw material costs significantly.

Dositicon Co., Ltd. faced a notable decline in its stock price, contrasting with the broader market's performance. Despite recent challenges, including a decrease in net sales and low management efficiency, the company has achieved significant annual growth over the past year, outperforming the market index.

Dositicon Co., Ltd. has shown notable stock performance, gaining 3.7% on February 27, 2026, despite a decline in the China Shanghai Composite. The company has achieved a 350.31% return over the past year, although it faces challenges in management efficiency and declining long-term sales.

Dositicon Co., Ltd. has shown notable performance, gaining 3.33% on February 26, 2026, despite a declining market. Over the past year, it achieved a 322.4% return, significantly outperforming the broader market. The company has reported positive results for three consecutive quarters, highlighting its resilience and strong cash flow.